XNAS · ATOS
-0.39% · -$0.0100 · Vol 23.7K
Live · updated 11:44:08 ET
Atossa Therapeutics, Inc. Common Stock

Atossa Therapeutics, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$2.53
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
ATOS
Atossa Therapeutics, Inc. Common Stock
Fri Aug 21 · last completed session · daily score · 2d 18h old
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

48/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 21 · last completed session · daily score · 2d 18h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ATOS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ATOS catalysts
About Atossa Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2012
Employees
14
Country
US

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.56
Day high
$2.56
Day low
$2.45
Previous close
$2.54
52W high
$17.70
-85.71% from high
52W low
$1.75
5% of range
Market cap
$25.3M
EPS
$-2.2000
Beta
-0.33
Shares out
10M
Volume
23.7K
0.34× rel vol
Avg volume
69.5K
VWAP
$2.50
Price history computed in-house
1W
-9.32%
1M
+10.24%
3M
-48.89%
1Y
-78.31%
YTD
-71.41%
SMA 50 $2.30 · above
SMA 200 $6.07 · below
52W position 5%

ATOS overview

Veridion Score
48
Registered · 2026-08-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ATOS.Congress disclosuresOpen receipt and filing context for ATOS.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ATOS Form 4 filings
Public disclosures

Congress activity in ATOS

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ATOS in the cached public ledger.

Federal contracts

ATOS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ATOS in this window.
Lobbying spend

ATOS lobbying filings, year to date.

Registered lobbying filings matched to Atossa Therapeutics, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ATOS in this window.
Loading news for ATOS
Analyst ratings
Sovereign unlock shows live analyst consensus for ATOS.
Options
Sovereign unlock shows live options positioning for ATOS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.